Health service users’ experiences of issues such as systems and medical teams not talking to each other, never mind patients, ...

Technology, a need for investment and the collective effort required to achieve “neighbourhood health” were on the agenda as ...

Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Third Quarter 2025 Earnings Conference Call.

Q3 2025 Earnings Call Transcript November 13, 2025 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS ...

Operator: Good morning, everyone. And welcome to the Abeona Therapeutics third quarter 2025 conference call. At this time, ...

Guidance Raised -- 2025 revenue target increased to $80.5 million–$81.5 million, midpoint 38.7% growth; net income projected ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

Stifel 2025 Healthcare Conference November 12, 2025 4:40 PM ESTCompany ParticipantsRachel McMinn - Founder, Executive Chair ...

Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers ...

Johnson & Johnson ( JNJ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 11, 2025 10:30 AM EST ...

Countless people worldwide suffer from chronic pain that affects their quality of life and drives up healthcare costs. In ...

The first healthcare simulation certification programmes designed specifically for Southeast Asian professionals were ...